Cargando…
Influence of corticosteroid treatment on CXCR4 expression in DLBCL
BACKGROUND: CXCR4-targeted radioligand therapy (RLT) with [(177)Lu]Lu/[(90)Y]Y-PentixaTher has recently evolved as a promising therapeutic option for patients with advanced hematological cancers. Given their advanced disease stage, most patients scheduled for PentixaTher RLT require concomitant or b...
Autores principales: | Martin, Sebastian, Viertl, David, Janz, Anna, Habringer, Stefan, Keller, Ulrich, Schottelius, Margret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172459/ https://www.ncbi.nlm.nih.gov/pubmed/37162652 http://dx.doi.org/10.1186/s13550-023-00993-4 |
Ejemplares similares
-
Validation of [(125)I]CPCR4.3 as an investigative tool for the sensitive and specific detection of hCXCR4 and mCXCR4 expression in vitro and in vivo
por: Schottelius, Margret, et al.
Publicado: (2019) -
Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo — a comparison to [(68)Ga]pentixafor
por: Poschenrieder, Andreas, et al.
Publicado: (2016) -
Response assessment with the CXCR4-directed positron emission tomography tracer [(68)Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities
por: Herhaus, Peter, et al.
Publicado: (2017) -
In Vivo Targeting of CXCR4—New Horizons
por: Schottelius, Margret, et al.
Publicado: (2021) -
CXCR4-directed theranostics in oncology and inflammation
por: Kircher, Malte, et al.
Publicado: (2018)